Intraoperative and early postoperative chemotherapy into the abdominal cavity using gemcitabine may prevent postoperative occurence of peritoneal carcinomatosis.

MLA

Ridwelski, Karsten, et al. “Intraoperative and Early Postoperative Chemotherapy into the Abdominal Cavity Using Gemcitabine May Prevent Postoperative Occurence of Peritoneal Carcinomatosis.” Journal of Surgical Oncology, vol. 79, no. 1, Jan. 2002, pp. 10–16. EBSCOhost, https://doi.org/10.1002/jso.10000.

APA

Ridwelski, K., Meyer, F., Hribaschek, A., Kasper, U., & Lippert, H. (2002). Intraoperative and early postoperative chemotherapy into the abdominal cavity using gemcitabine may prevent postoperative occurence of peritoneal carcinomatosis. Journal of Surgical Oncology, 79(1), 10–16. https://doi.org/10.1002/jso.10000

Chicago

Ridwelski, Karsten, Frank Meyer, Arndt Hribaschek, Udo Kasper, and Hans Lippert. 2002. “Intraoperative and Early Postoperative Chemotherapy into the Abdominal Cavity Using Gemcitabine May Prevent Postoperative Occurence of Peritoneal Carcinomatosis.” Journal of Surgical Oncology 79 (1): 10–16. doi:10.1002/jso.10000.